These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1288432)
1. Evaluation of hepatic fibrosis after oxamniquine therapy of murine schistosomiasis. Morcos SH; Mansour MM; Khayyal MT; Saleh S; Ishak EA; Girgis NI Ann Trop Med Parasitol; 1992 Oct; 86(5):511-6. PubMed ID: 1288432 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice. Amin AM; Mikhail EG J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251 [TBL] [Abstract][Full Text] [Related]
3. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis. Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036 [TBL] [Abstract][Full Text] [Related]
4. Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity. Botros S; Soliman A; el-Gawhary N; Selim M; Guirguis N Trans R Soc Trop Med Hyg; 1989; 83(1):86-9. PubMed ID: 2513673 [TBL] [Abstract][Full Text] [Related]
5. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis. Lambertucci JR; Modha J; Curtis R; Doenhoff M Trans R Soc Trop Med Hyg; 1989; 83(3):354-7. PubMed ID: 2515622 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody. Fallon PG; Hamilton JV; Doenhoff MJ Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991 [TBL] [Abstract][Full Text] [Related]
7. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study. Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase]. Campos R; Pinto PL; Amato Neto V; Moreira AA Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575 [TBL] [Abstract][Full Text] [Related]
9. Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis. Morcos SH; Khayyal MT; Mansour MM; Saleh S; Ishak EA; Girgis NI; Dunn MA Am J Trop Med Hyg; 1985 Mar; 34(2):314-21. PubMed ID: 3985273 [TBL] [Abstract][Full Text] [Related]
11. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni. Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757 [TBL] [Abstract][Full Text] [Related]
12. Treatment of schistosomiasis mansoni with oxamniquine--five years' experience. Kilpatrick ME; Farid Z; Bassily S; El-Masry NA; Trabolsi B; Watten RH Am J Trop Med Hyg; 1981 Nov; 30(6):1219-22. PubMed ID: 7325280 [TBL] [Abstract][Full Text] [Related]
13. Repeated infections with Schistosoma mansoni and liver fibrosis in undernourished mice. Coutinho EM; Silva FL; Barros AF; Araújo RE; Oliveira SA; Luna CF; Barbosa AA; Andrade ZA Acta Trop; 2007 Jan; 101(1):15-24. PubMed ID: 17194437 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515 [TBL] [Abstract][Full Text] [Related]
15. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni. Araujo N; Mattos AC; Coelho PM; Katz N Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417 [TBL] [Abstract][Full Text] [Related]
16. Tolerance of Kenyan Schistosoma mansoni to oxamniquine. Coles GC; Mutahi WT; Kinoti GK; Bruce JI; Katz N Trans R Soc Trop Med Hyg; 1987; 81(5):782-5. PubMed ID: 3130689 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment. Katz N; Rocha RS; de Souza CP; Coura Filho P; Bruce JI; Coles GC; Kinoti GK Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880 [TBL] [Abstract][Full Text] [Related]
18. Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis. Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; Megahed N Parasitol Int; 2017 Oct; 66(5):545-554. PubMed ID: 28408356 [TBL] [Abstract][Full Text] [Related]
19. ELISA detection of specific circulating antibodies against Schistosoma mansoni in mice after treatment with oxamniquine. Coelho PM; Tavares CA Braz J Med Biol Res; 1991; 24(5):485-93. PubMed ID: 1823263 [TBL] [Abstract][Full Text] [Related]